On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Stocks To Buy Now

Blog


Eat Well Investment Group Inc. (CSE: EWG) (OTC: EWGFF) (FRA: 6BC0) Set to Meet 2022 Revenue Target

  • In 2021, Eat Well acquired Belle Pulses Ltd. Sapientia Technologies Inc. and a 51% stake at Amara Organic Foods
  • These acquisitions saw a 1,082% growth in the company’s assets for the 2021 financial year and a 320% revenue growth for Amara
  • With the plant-based foods market projected to be valued at $162 billion by 2030, Eat Well expects to capitalize on this growth through M&As and strategic partnerships with key players in the industry
  • Eat Well is confident that with the foundation laid down so far, it is poised to achieve $100 million in revenue for 2022
At the close of the 2021 calendar year, Eat Well Investment Group (CSE: EWG) (OTC: EWGFF) (FRA: 6BC0) was regarded as “One to Watch.”  This mainly stemmed from its aggressive market expansion plans, vertical integration, and the bolstering of its leadership (https://ibn.fm/tFGDP). Over the course of the year, Eat Well proved how well its management was at sourcing, financing, and building successful companies. Together, these individuals had financed and invested in early-stage venture companies for over 25 years. The experience would allow Eat Well to acquire Belle Pulses Ltd., 100% of Sapientia Technologies Inc., and 51% shares at Amara Organic Foods. Consequently, the acquisitions would see the addition of revenue channels for Eat Well, setting the company on the road to targeting approximately $100 million in revenue for the 2022 financial year. On June 10, 2022, Eat Well released its fourth-quarter and full-year financial results for 2021, marking a 1,082% growth in assets from the previous year. Amara would post the highest revenue growth at 320% from 2020, mainly influenced by its “toddler melts” product launch across North American retail. Given its performance, Eat Well’s management expressed its optimism for 2022, citing the growth of the plant-based foods market and how well-positioned its portfolio companies are to take advantage of this growth (https://ibn.fm/UKidY). “We have laid a strong foundation within the Eat Well Group investment platform, and we are very enthusiastic about the trajectory of our portfolio,” noted Marc Aneed, Eat Well’s Director, President, and Chief Executive Officer (“CEO”). “Our portfolio companies are well positioned to capture global pulse demand and accelerate the scale of their better-for-you consumer products for years to come,” he added. It is projected that the plant-based foods market will comprise up to 7.7% of the global protein market by 2030, valued at $162 billion, up from $29.4 billion in 2020. Many analysts have even likened the food tech market to the early days of the internet in that plant-based foods represent a worldwide secular trend of steady growth and potential that will revolutionize how society functions and people experience nutrition. Through Eat Well’s aggressive yet strategic merger and acquisition (“M&A”) transactions, the company is positioning itself to take advantage of this shift in consumer preference and the growing plant-based industry. As of December 2021, Amara’s revenues had grown by over 400% since the beginning of the year, drawing media coverage from outlets such as TechCrunch and Forbes and highlighting the tremendous potential for growth for Eat Well Investment Group. Today, Eat Well supplies big companies such as Beyond Meat, Nestle, Ingredion, and General Mills, among others. As time progresses, it looks to strengthen its distribution network and its relationship with strategic partners to create value for its shareholders with its projected $100 million revenue target for 2022. For more information, visit the company’s website at www.EatWellGroup.com. NOTE TO INVESTORS: The latest news and updates relating to EWGFF are available in the company’s newsroom at https://ibn.fm/EWGFF

From Our Blog

“Urgent Action: PaxMedica Inc. (NASDAQ: PXMD) Addresses Medical Crisis in Malawi”

April 24, 2024

In recent developments, PaxMedica (NASDAQ: PXMD), a renowned biopharmaceutical company specializing in treatments for neurological disorders, has taken swift action to address a pressing medical situation unfolding in Malawi, East Africa. The Ministry of Health (“MOH”) of Malawi has issued a plea for access to IV suramin, a vital medication in combating the life-threatening sleeping […]

Rotate your device 90° to view site.